Influence of infliximab on circulating osteoprotegerin and its prognostic value in patients with rheumatoid arthritis

被引：0
|
作者：
Korzh, OM [1 ]
机构：
[1] Natl Univ Pharm, Kharkov, Ukraine
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2004年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：249 / 250
页数：2
相关论文
共 50 条
  • [41] THE DIAGNOSTIC AND PROGNOSTIC VALUE OF AUTOANTIBODIES IN RHEUMATOID ARTHRITIS
    Sieghart, D.
    Platzer, A.
    Alasti, F.
    Studenic, P.
    Grundhuber, M.
    Swiniarski, S.
    Blueml, S.
    Perkmann, T.
    Smolen, J.
    Steiner, G.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : A24 - A25
  • [42] Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patients
    Finckh, Axel
    Dudler, Jean
    Wermelinger, Felix
    Ciurea, Adrian
    Kyburz, Diego
    Gabay, Cem
    Bas, Sylvette
    [J]. JOINT BONE SPINE, 2010, 77 (04) : 313 - 318
  • [43] PROGNOSTIC VALUE OF RHEUMATOID FACTORS IN RHEUMATOID-ARTHRITIS - REPLY
    WOLFE, F
    [J]. JOURNAL OF RHEUMATOLOGY, 1995, 22 (03) : 571 - 571
  • [44] EFFECT OF INFLIXIMAB TREATMENT ON CIRCULATING MONOCYTES IN RHEUMATOID ARTHRITIS PATIENTS: DIFFERENCES BETWEEN EARLY AND LATE DISEASE
    Coulthard, Lydia R.
    Mathews, Rebeccah J.
    Church, Leigh D.
    Cooper, Dawn
    Wong, Chi
    Bryer, Domini
    Buch, Maya
    Emery, Paul
    Morgan, Ann W.
    McDermott, Michael F.
    [J]. ADVANCES IN TNF FAMILY RESEARCH, 2011, 691 : 786 - 787
  • [45] Infliximab inhibits bone resorption by circulating osteoclast precursor cells in patients with rheumatoid arthritis and ankylosing spondylitis
    Gengenbacher, M.
    Sebald, H-J
    Villiger, P. M.
    Hofstetter, W.
    Seitz, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (05) : 620 - 624
  • [46] Circulating osteoprotegerin levels are elevated in rheumatoid arthritis: a systematic review and meta-analysis
    Peng Wang
    Si Li
    Li-Na Liu
    Tian-Tian Lv
    Xiao-Mei Li
    Xiang-Pei Li
    Hai-Feng Pan
    [J]. Clinical Rheumatology, 2017, 36 : 2193 - 2200
  • [47] Discontinuation of infliximab in rheumatoid arthritis patients in clinical remission
    Nawata, Masao
    Saito, Kazuyoshi
    Nakayamada, Shingo
    Tanaka, Yoshiya
    [J]. MODERN RHEUMATOLOGY, 2008, 18 (05) : 460 - 464
  • [48] Outcomes of infliximab dose escalation in patients with rheumatoid arthritis
    Cohen, Stanley B.
    Kremer, Joel M.
    Dandreo, Kimberly J.
    Reed, George W.
    Magner, Robert
    Shan, Ying
    Kafka, Shelly
    DeHoratius, Raphael J.
    Ellis, Lorie
    Parenti, Dennis
    [J]. CLINICAL RHEUMATOLOGY, 2019, 38 (09) : 2501 - 2508
  • [49] Infliximab reduces BMD loss in patients with rheumatoid arthritis
    [J]. Nature Clinical Practice Rheumatology, 2007, 3 (2): : 69 - 69
  • [50] Safety of infliximab in daily practice in patients with rheumatoid arthritis
    Neven, N
    Vis, M
    Voskuyl, AE
    Wolbink, GJ
    Nurmohamed, M
    Dijkmans, BAC
    Lems, WF
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 175 - 175
12345